QC
RLYB icon

Quadrature Capital’s Rallybio RLYB Stock Holding History

Quadrature Capital’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208K Buy
+12,995
New +$167K ﹤0.01% 1342

Other funds holding RLYB

PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VGA
Vanguard Global Advisers Malvern, Pennsylvania $215B AUM

Quadrature Capital's RLYB Position: Q2 2026 in Review

Quadrature Capital opened a new position in Rallybio (RLYB) in Q2 2026: 12,995 shares worth $208K. The stake represents ﹤0.01% of the portfolio and ranks #1342 among its holdings.

24 funds tracked by Wall St. Rank hold RLYB as of Q2 2026.

  • Quadrature Capital held 12,995 shares of Rallybio worth $208K as of Q2 2026.
  • Rallybio was a new Quadrature Capital position in Q2 2026.
  • Rallybio made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1342 holding.
  • 24 funds tracked by Wall St. Rank held Rallybio as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.